Mtx Ratiopharm (Methotrexate)

Methotrexate, the active ingredient in Mtx Ratiopharm, is an antimetabolite (folate antagonist) presented as a subcutaneous injection for subcutaneous use. It is used to treat rheumatoid arthritis, psoriasis, certain cancers and ectopic pregnancy in appropriate patients.

GNH USA supplies Mtx Ratiopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methotrexate is employed in autoimmune and oncologic conditions where it modulates immune response or inhibits cell proliferation.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin lesion severity and plaque formation. - Certain malignancies (e.g., leukemia, lymphoma): interferes with cancer cell DNA synthesis leading to tumor growth inhibition. - Ectopic pregnancy: terminates trophoblastic tissue to avoid surgical intervention.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Fatigue or malaise. - Mild oral ulcers. - Transient elevation of liver enzymes. - Mild hair thinning.

Serious or Rare Side Effects: - Severe hepatotoxicity or fibrosis. - Myelosuppression leading to pancytopenia. - Pulmonary toxicity (interstitial pneumonitis). - Severe mucosal ulceration or stomatitis. - Renal impairment due to crystal nephropathy.

Methotrexate requires careful monitoring and specific safety measures before and during therapy.

- Pregnancy: contraindicated (Category X) – avoid use in pregnant women. - Renal function: assess baseline and monitor regularly – dose adjustment may be required. - Liver function: perform periodic liver enzyme tests – risk of hepatotoxicity. - Blood counts: conduct regular complete blood counts – monitor for myelosuppression. - Concomitant NSAIDs or aspirin: use with caution – may increase renal and gastrointestinal toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methotrexate interacts with several drugs that can alter its efficacy or toxicity.

Major Interactions (Avoid): - Live vaccines: contraindicated – may cause infection. - Trimethoprim‑sulfamethoxazole: may increase hematologic toxicity. - High‑dose aspirin or NSAIDs: increase risk of renal toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce methotrexate plasma levels. - Proton pump inhibitors: may affect absorption and increase gastrointestinal side effects. - Alcohol: may exacerbate hepatotoxicity.